{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T18:56:56Z","timestamp":1769108216791,"version":"3.49.0"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["JAHA"],"published-print":{"date-parts":[[2015,12]]},"abstract":"<jats:sec xml:lang=\"en\">\n            <jats:title>Background<\/jats:title>\n            <jats:p xml:lang=\"en\">\n              Transient nonfocal neurological symptoms may serve as markers of cardiac dysfunction. We assessed whether serum N\u2010terminal pro\u2013brain natriuretic peptide (\n              <jats:styled-content style=\"fixed-case\">NT<\/jats:styled-content>\n              \u2010pro\n              <jats:styled-content style=\"fixed-case\">BNP)<\/jats:styled-content>\n              levels, a biomarker of cardiac disease, are increased in patients with transient ischemic attack\n              <jats:styled-content style=\"fixed-case\">(TIA)<\/jats:styled-content>\n              accompanied by nonfocal symptoms and in patients with attacks of nonfocal symptoms (transient neurological attack [\n              <jats:styled-content style=\"fixed-case\">TNA]<\/jats:styled-content>\n              ).\n            <\/jats:p>\n          <\/jats:sec>\n          <jats:sec xml:lang=\"en\">\n            <jats:title>Methods and Results<\/jats:title>\n            <jats:p xml:lang=\"en\">\n              We included 15 patients with\n              <jats:styled-content style=\"fixed-case\">TNA<\/jats:styled-content>\n              , 69 with\n              <jats:styled-content style=\"fixed-case\">TIA<\/jats:styled-content>\n              accompanied by nonfocal symptoms, 58 with large\u2010vessel\n              <jats:styled-content style=\"fixed-case\">TIA<\/jats:styled-content>\n              , 32 with cardioembolic\n              <jats:styled-content style=\"fixed-case\">TIA<\/jats:styled-content>\n              , and 46 age\u2010 and sex\u2010matched healthy control participants. Serum\n              <jats:styled-content style=\"fixed-case\">NT<\/jats:styled-content>\n              \u2010pro\n              <jats:styled-content style=\"fixed-case\">BNP<\/jats:styled-content>\n              levels were determined within 1\u00a0week after the attack. We compared log\u2010transformed\n              <jats:styled-content style=\"fixed-case\">NT<\/jats:styled-content>\n              \u2010pro\n              <jats:styled-content style=\"fixed-case\">BNP<\/jats:styled-content>\n              levels of patients with cardioembolic\n              <jats:styled-content style=\"fixed-case\">TIA<\/jats:styled-content>\n              s and mixed or nonfocal\n              <jats:styled-content style=\"fixed-case\">TNA<\/jats:styled-content>\n              s, with those of patients with noncardioembolic\n              <jats:styled-content style=\"fixed-case\">TIA<\/jats:styled-content>\n              s as a reference group. Adjustments for age, sex, atrial fibrillation, and a history of nonischemic heart disease were made with a multiple linear regression model. Compared with large\u2010vessel\n              <jats:styled-content style=\"fixed-case\">TIA<\/jats:styled-content>\n              (mean 14.2\u00a0pmol\/L), mean\n              <jats:styled-content style=\"fixed-case\">NT<\/jats:styled-content>\n              \u2010pro\n              <jats:styled-content style=\"fixed-case\">BNP<\/jats:styled-content>\n              levels were significantly higher in patients with\n              <jats:styled-content style=\"fixed-case\">TIA<\/jats:styled-content>\n              accompanied by nonfocal symptoms (40.5\u00a0pmol\/L,\n              <jats:italic>P<\/jats:italic>\n              =0.049) and with cardioembolic\n              <jats:styled-content style=\"fixed-case\">TIA<\/jats:styled-content>\n              (123.5\u00a0pmol\/L;\n              <jats:italic>P<\/jats:italic>\n              =0.004) after adjustments for age, sex, atrial fibrillation, and a history of nonischemic heart disease. Patients with\n              <jats:styled-content style=\"fixed-case\">TNA<\/jats:styled-content>\n              also had higher mean\n              <jats:styled-content style=\"fixed-case\">NT<\/jats:styled-content>\n              \u2010pro\n              <jats:styled-content style=\"fixed-case\">BNP<\/jats:styled-content>\n              levels (20.8\u00a0pmol\/L,\n              <jats:italic>P<\/jats:italic>\n              =0.38) than those with large\u2010vessel\n              <jats:styled-content style=\"fixed-case\">TIA<\/jats:styled-content>\n              , but this difference was not statistically significant.\n            <\/jats:p>\n          <\/jats:sec>\n          <jats:sec xml:lang=\"en\">\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p xml:lang=\"en\">\n              <jats:styled-content style=\"fixed-case\">NT<\/jats:styled-content>\n              \u2010pro\n              <jats:styled-content style=\"fixed-case\">BNP<\/jats:styled-content>\n              levels are increased in patients with\n              <jats:styled-content style=\"fixed-case\">TIA<\/jats:styled-content>\n              accompanied by nonfocal symptoms.\n            <\/jats:p>\n          <\/jats:sec>","DOI":"10.1161\/jaha.115.002072","type":"journal-article","created":{"date-parts":[[2015,12,16]],"date-time":"2015-12-16T02:44:33Z","timestamp":1450233873000},"update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":6,"title":["N\u2010Terminal Pro\u2013Brain Natriuretic Peptide (NT\u2010proBNP) Levels are Increased in Patients With Transient Ischemic Attack Accompanied by Nonfocal Symptoms"],"prefix":"10.1161","volume":"4","author":[{"given":"Gerben J. J.","family":"Plas","sequence":"first","affiliation":[{"name":"Department of Neurology Medical Spectrum Twente Enschede The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanne D.","family":"Jurg","sequence":"additional","affiliation":[{"name":"Department of Neurology Medical Spectrum Twente Enschede The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marjolein","family":"Brusse\u2010Keizer","sequence":"additional","affiliation":[{"name":"Medical School Twente Medical Spectrum Twente Enschede The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diederik W. J.","family":"Dippel","sequence":"additional","affiliation":[{"name":"Department of Neurology Erasmus Medical Center Rotterdam The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter J.","family":"Koudstaal","sequence":"additional","affiliation":[{"name":"Department of Neurology Erasmus Medical Center Rotterdam The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heleen M.","family":"den Hertog","sequence":"additional","affiliation":[{"name":"Department of Neurology Medical Spectrum Twente Enschede The Netherlands"},{"name":"Department of Neurology Erasmus Medical Center Rotterdam The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(92)92170-K"},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.298.24.2877"},{"key":"e_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000151103.02424.c3"},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2007.09.021"},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.24.1.35"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1159\/000363279"},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1747-4949.2011.00606.x"},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2014.02.014"},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2013.01.012"},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1155\/2009\/351591"},{"key":"e_1_3_1_12_2","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.48.1475"},{"key":"e_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.284.6327.1437"},{"key":"e_1_3_1_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/0303-8467(91)90049-U"}],"container-title":["Journal of the American Heart Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/JAHA.115.002072","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T09:58:45Z","timestamp":1715594325000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/JAHA.115.002072"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":13,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["10.1161\/JAHA.115.002072"],"URL":"https:\/\/doi.org\/10.1161\/jaha.115.002072","relation":{},"ISSN":["2047-9980"],"issn-type":[{"value":"2047-9980","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"2015-05-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2015-11-01","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2015-12-15","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e002072"}}